Cargando…

Biodistribution of (131)I in mice is influenced by circadian variations

Effects of radiation and biodistribution of radionuclides are often studied in animal models. Circadian rhythm affects many biological functions and may influence the biokinetics of radionuclides and observed responses. The aim of this study was to investigate if the time during the day of (131)I in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersson, Charlotte K., Elvborn, Mikael, Spetz, Johan K. E., Langen, Britta, Forssell-Aronsson, Eva B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511401/ https://www.ncbi.nlm.nih.gov/pubmed/32968085 http://dx.doi.org/10.1038/s41598-020-72180-7

Ejemplares similares

Deconvolution of expression microarray data reveals (131)I-induced responses otherwise undetected in thyroid tissue
por: Langen, Britta, et al.
Publicado: (2018)

Circadian rhythm influences genome-wide transcriptional responses to (131)I in a tissue-specific manner in mice
por: Langen, Britta, et al.
Publicado: (2015)

Transcriptional response to (131)I exposure of rat thyroid gland
por: Rudqvist, Nils, et al.
Publicado: (2017)

Gene expression signature in mouse thyroid tissue after (131)I and (211)At exposure
por: Rudqvist, Nils, et al.
Publicado: (2015)

Age-related long-term response in rat thyroid tissue and plasma after internal low dose exposure to (131)I
por: Larsson, Malin, et al.
Publicado: (2022)

Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
por: Larsson, Malin, et al.
Publicado: (2020)

Correction: Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose 131I exposure
por: Larsson, Malin, et al.
Publicado: (2021)

Hyperfractionated Treatment with (177)Lu-Octreotate Increases Tumor Response in Human Small-Intestine Neuroendocrine GOT1 Tumor Model
por: Elvborn, Mikael, et al.
Publicado: (2022)

Transcriptional response in normal mouse tissues after i.v. (211)At administration - response related to absorbed dose, dose rate, and time
por: Langen, Britta, et al.
Publicado: (2015)

Non-targeted transcriptomic effects upon thyroid irradiation: similarity between in-field and out-of-field responses varies with tissue type
por: Langen, Britta, et al.
Publicado: (2016)

Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models
por: Josefsson, Anders, et al.
Publicado: (2014)

Hedgehog inhibitor sonidegib potentiates (177)Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice
por: Spetz, Johan, et al.
Publicado: (2017)

Age and sex effects across the blood proteome after ionizing radiation exposure can bias biomarker screening and risk assessment
por: Langen, Britta, et al.
Publicado: (2022)

Transcriptional Response in Mouse Thyroid Tissue after (211)At Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after Administration
por: Rudqvist, Nils, et al.
Publicado: (2015)

The IRI-DICE hypothesis: ionizing radiation-induced DSBs may have a functional role for non-deterministic responses at low doses
por: Langen, Britta, et al.
Publicado: (2020)

Priming increases the anti-tumor effect and therapeutic window of (177)Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1
por: Dalmo, Johanna, et al.
Publicado: (2017)

Transcriptional effects of (177)Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice
por: Spetz, Johan, et al.
Publicado: (2019)

Effects of internal low-dose irradiation from (131)I on gene expression in normal tissues in Balb/c mice
por: Schüler, Emil, et al.
Publicado: (2011)

Multiparametric MR for non‐invasive evaluation of tumour tissue histological characteristics after radionuclide therapy
por: Montelius, Mikael, et al.
Publicado: (2019)

Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to (177)Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor
por: Montelius, Mikael, et al.
Publicado: (2018)

Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer
por: Sandblom, Viktor, et al.
Publicado: (2019)

Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors
por: Sandblom, Viktor, et al.
Publicado: (2020)

Analysis of inter-patient variations in tumour growth rate
por: Mehrara, Esmaeil, et al.
Publicado: (2014)

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease
por: Happel, Christian, et al.
Publicado: (2023)

Neuroblastoma xenograft models demonstrate the therapeutic potential of (177)Lu-octreotate
por: Romiani, Arman, et al.
Publicado: (2021)

Tumour size measurement in a mouse model using high resolution MRI
por: Montelius, Mikael, et al.
Publicado: (2012)

Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancer.
por: Ledermann, J. A., et al.
Publicado: (1993)

Microdosimetric analysis of (211)At in thyroid models for man, rat and mouse
por: Josefsson, Anders, et al.
Publicado: (2012)

Co-administration with A1M does not influence apoptotic response of (177)Lu-octreotate in GOT1 neuroendocrine tumors
por: Rassol, Nishte, et al.
Publicado: (2023)

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

A Phase 1 Study of (131)I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety
por: Grudzinski, Joseph J., et al.
Publicado: (2014)

Data‐driven identification of tumor subregions based on intravoxel incoherent motion reveals association with proliferative activity
por: Jalnefjord, Oscar, et al.
Publicado: (2019)

Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after (177)Lu-DOTA-Tyr(3)-octreotate treatment: a histological study in xenografted mice
por: Erlandsson, Ann, et al.
Publicado: (2011)

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.
por: Lane, D. M., et al.
Publicado: (1994)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

The Influence of Antithyroid Drug Discontinuation to the Therapeutic Efficacy of (131)I in Hyperthyroidism
por: Kartamihardja, A. Hussein Sundawa, et al.
Publicado: (2016)

I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
por: Carrasquillo, Jorge A., et al.
Publicado: (2018)

Interventional therapy for human breast cancer in nude mice with (131)I gelatin microspheres ((131)I-GMSs) following intratumoral injection
por: Li, Chuan-Chao, et al.
Publicado: (2014)

Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of (131)I during radioiodine therapy of Graves’ disease
por: Happel, C., et al.
Publicado: (2021)

Distinct microRNA Expression Profiles in Mouse Renal Cortical Tissue after (177)Lu-octreotate Administration
por: Schüler, Emil, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2jcuoqsid6506ilf9muj7ptfqu